HPLC data are represented as graphs showing relative growth inhibition compared to control cell growth (± standard deviation).
Figure 1 A and B: Incubation of water extracts of LD at 1 10, 1 100 and 1 1000 on the HL60 and HT29 cell lines for 24, 48 and 72 hours compared to normal (control) cell growth, ± standard deviation from the mean, *denotes statistical significance (p = 0.05).
AH: Adult height; BA: Bone age; BMI: Body mass index; GHD: Growth hormone deficiency; GnRH: Gonadotropin-releasing hormone; IGF: Insulin-like growth factor; SDS: Standard deviation score; TH: Target height.
On the other hand, a trend of growth in the standard deviation of mean estimates σ μ with increase of mean intensities across the dynamic range is not certain (in blue in Figure 1) and even σ μ = const cannot be excluded (the case of purely systematic error).
This number is identical to the 4-h growth; however, the standard deviation has doubled.
Moreover, we observe the growth of the standard deviation σs for both measures.
The growth distance and standard deviation and the microstructure evolution along the single crystal matrix interface are used to locally characterize the change in migration behavior as a function of temperature, time and interface orientation.
However, during prolonged growth only 54.3% (standard deviation (SD) = 4.6; about 400 cells of three cultures each were determined) of the mutant cells further developed into filaments of normal true hyphae appearance, whereas 91.3% (SD = 1.4) of wild-type cells and 75.6% (SD = 3.9) of the heterozygous and 79.6 (SD = 2.4) of the reintegrated cells showed normal appearance.
BMI, body mass index; IGF, insulin-like growth factor; SDS, standard deviation score.
BMI = body mass index; CRP = C-reactive protein; 1CTP = C-terminal propeptide of type I collagen; CTX = C-terminal telopeptides crosslaps; ESR = erythrocyte sedimentation rate; IGFSD = insulin-like growth factor-1, standard deviation scores; IL-6 = interleukin-6; ns = not significant; P1NP = Procollagen type I N-terminal propeptide.
